Rayence Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Rayence is forecast to grow earnings and revenue by 6.2% and 6.5% per annum respectively. EPS is expected to grow by 4.4% per annum. Return on equity is forecast to be 6.7% in 3 years.
Wichtige Informationen
6.2%
Wachstumsrate der Gewinne
4.4%
EPS-Wachstumsrate
Medical Equipment Gewinnwachstum | 33.5% |
Wachstumsrate der Einnahmen | 6.5% |
Zukünftige Eigenkapitalrendite | 6.7% |
Analystenabdeckung | Low |
Zuletzt aktualisiert | 12 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Lacklustre Performance Is Driving Rayence Co., Ltd.'s (KOSDAQ:228850) Low P/E
Aug 12Rayence's (KOSDAQ:228850) Profits May Not Reveal Underlying Issues
May 25We Think Rayence (KOSDAQ:228850) Can Stay On Top Of Its Debt
Mar 31Rayence Co., Ltd. (KOSDAQ:228850) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?
Mar 05Will Rayence (KOSDAQ:228850) Multiply In Value Going Forward?
Feb 17Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02Rayence's(KOSDAQ:228850) Share Price Is Down 44% Over The Past Three Years.
Jan 18Should Rayence Co., Ltd. (KOSDAQ:228850) Be Part Of Your Dividend Portfolio?
Jan 06Income Investors Should Know That Rayence Co., Ltd. (KOSDAQ:228850) Goes Ex-Dividend Soon
Dec 25At ₩11,100, Is It Time To Put Rayence Co., Ltd. (KOSDAQ:228850) On Your Watch List?
Dec 14Rayence (KOSDAQ:228850) Seems To Use Debt Quite Sensibly
Dec 01A Look At The Intrinsic Value Of Rayence Co., Ltd. (KOSDAQ:228850)
Nov 18Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 157,750 | 19,000 | 9,300 | 17,750 | 2 |
12/31/2025 | 145,650 | 16,150 | 4,100 | 14,450 | 2 |
12/31/2024 | 134,200 | 13,750 | -6,300 | 13,900 | 2 |
6/30/2024 | 136,322 | 17,558 | 18,175 | 27,730 | N/A |
3/31/2024 | 141,121 | 20,963 | 18,925 | 26,687 | N/A |
12/31/2023 | 142,986 | 19,600 | 22,779 | 25,820 | N/A |
9/30/2023 | 145,736 | 21,118 | 20,179 | 23,519 | N/A |
6/30/2023 | 148,751 | 19,975 | 27,824 | 28,279 | N/A |
3/31/2023 | 148,640 | 19,932 | 22,970 | 25,073 | N/A |
12/31/2022 | 147,161 | 22,049 | 14,687 | 16,607 | N/A |
9/30/2022 | 146,257 | 21,570 | 17,712 | 19,084 | N/A |
6/30/2022 | 140,174 | 18,239 | 10,758 | 12,832 | N/A |
3/31/2022 | 139,207 | 13,087 | 13,571 | 15,534 | N/A |
12/31/2021 | 134,568 | 14,458 | 19,235 | 20,939 | N/A |
9/30/2021 | 129,291 | 4,328 | 17,654 | 18,022 | N/A |
6/30/2021 | 119,423 | 552 | 22,877 | 23,615 | N/A |
3/31/2021 | 105,745 | -25 | 12,926 | 16,528 | N/A |
12/31/2020 | 101,524 | -1,916 | 16,599 | 23,254 | N/A |
9/30/2020 | 106,506 | 4,466 | 9,928 | 21,172 | N/A |
6/30/2020 | 115,408 | 9,992 | 2,521 | 17,158 | N/A |
3/31/2020 | 125,120 | 14,398 | 5,654 | 23,653 | N/A |
12/31/2019 | 126,175 | 14,688 | -6,934 | 9,453 | N/A |
9/30/2019 | 120,608 | 16,018 | 2,298 | 15,344 | N/A |
6/30/2019 | 118,165 | 15,282 | 916 | 10,708 | N/A |
3/31/2019 | 116,220 | 16,006 | 10,666 | 14,657 | N/A |
12/31/2018 | 116,389 | 15,728 | 9,986 | 14,702 | N/A |
9/30/2018 | 114,811 | 18,597 | -202 | 5,835 | N/A |
6/30/2018 | 114,491 | 18,433 | 7,184 | 15,063 | N/A |
3/31/2018 | 110,391 | 16,389 | N/A | 15,800 | N/A |
12/31/2017 | 106,518 | 14,622 | N/A | 20,617 | N/A |
9/30/2017 | 108,483 | 15,477 | N/A | 22,446 | N/A |
6/30/2017 | 102,915 | 14,723 | N/A | 13,082 | N/A |
3/31/2017 | 100,789 | 14,598 | N/A | 10,148 | N/A |
12/31/2016 | 98,457 | 14,745 | N/A | 8,367 | N/A |
9/30/2016 | 93,980 | 14,072 | N/A | 8,112 | N/A |
6/30/2016 | 92,467 | 14,984 | N/A | 8,127 | N/A |
3/31/2016 | 88,681 | 14,513 | N/A | 12,573 | N/A |
12/31/2015 | 86,609 | 14,482 | N/A | 9,331 | N/A |
12/31/2014 | 77,943 | 3,217 | N/A | 7,072 | N/A |
12/31/2013 | 69,183 | 3,183 | N/A | 7,660 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: A228850's forecast earnings growth (6.2% per year) is above the savings rate (2.6%).
Ertrag vs. Markt: A228850's earnings (6.2% per year) are forecast to grow slower than the KR market (29.3% per year).
Hohe Wachstumserträge: A228850's earnings are forecast to grow, but not significantly.
Einnahmen vs. Markt: A228850's revenue (6.5% per year) is forecast to grow slower than the KR market (9.9% per year).
Hohe Wachstumseinnahmen: A228850's revenue (6.5% per year) is forecast to grow slower than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: A228850's Return on Equity is forecast to be low in 3 years time (6.7%).